The clinical information you need, at your fingertips.

Medical News for You

Company news

FDA OKs Evoxac oral solution for Sjögren’s disease dry mouth

The new formulation provides an alternative for adults who have difficulty swallowing capsules. . .

Company news

Tezspire delivers sustained remission in eosinophilic esophagitis

Nearly two-thirds of patients achieved histologic remission, with improvements in symptoms and endoscopic findings maintained through 52 weeks. . .

KFF

12h

Half of US adults think spacing out childhood vaccines is healthier

Spreading shots over more visits may appear to reduce risks, but it also adds trips and can make it more difficult to finish a series on time. . .

Science

14h

AI tops generalist physicians at diagnostic workup

The system gathered far more patient history than physicians before it ordered any tests. . .

JAMA Netw Open

17h

More pregnancy weight gain, more maternal risk?

Weight gain above recommended ranges was linked to higher rates of severe maternal complications across all BMI categories. . .

J Am Acad Dermatol

18h

New hidradenitis suppurativa guideline puts biologics at center of care

First-ever joint AAD-HSF guidance outlines an evidence-based roadmap for treating hidradenitis suppurativa, from topicals to biologics, surgery, pain management, and lifestyle measures. . .

CHEST 2026

20h

Acid suppressors linked to worse outcomes in biologic-treated asthma

Chronic empiric PPI use was associated with more exacerbations, infections, and healthcare utilization in patients receiving asthma biologics. . .

Gastroenterology

When ursodiol isn't enough: New guidance on treating PBC

Joint AGA/AASLD guidance endorses PPAR agonists for inadequate treatment response and offers new recommendations on diagnosis, risk stratification, and pruritus. . .

FDA

Hibsago approved for chronic hepatitis B, advancing the goal of functional cure

The first-in-class therapy helped some patients maintain viral control after treatment ended, potentially reducing reliance on lifelong antiviral therapy. . .